跳至主要内容
临床试验/NCT02500524
NCT02500524终止3 期

A Randomised, Controlled, Assessor-blind, Parallel Group Clinical Trial to Assess the Efficacy, Safety and Acceptability of a Surfactant Based Lotion and a Permethrin Creme Rinse in the Treatment of Head Lice

Medical Entomology Centre1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 1998年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
终止
发起方
入组人数
44
试验地点
1
主要终点
Elimination of infestation

研究概览

简要总结

To assess the efficacy and safety of 10% Cocamide DEA and Lyclear creme rinse (permethrin1%) in the eradication of head lice. To assess the ability of each product to kill all viable ova and to assess patient acceptability of the product in use.

详细描述

A formulation of cocamide diethanolamine (DEA) surfactant was previously reported as showing efficacy to eliminate head louse infestation. This study has been designed to test those data using a new formulation of 10% cocamide DEA in an aqueous basis in comparison with the standard of care product 1% permethrin creme rinse. It is believed that surfactants like cocamide DEA are capable of eliminating lice resistant to conventional insecticides.

A planned total of 120 patients who, following examination, are found to suffer from active head lice infestation will be recruited to the trial. The patient will be treated with the appropriate product according to the randomization code from a pre-prepared listing in balanced blocks of 12.

10% Cocamide DEA is applied directly to dry hair and is washed off with shampoo after 60 minutes. Permethrin 1% creme rinse is applied to shampooed and towel dried hair and left in situ for 10 minutes, then rinsed off with clean water. Treatments will be applied by experienced investigators throughout the study. Assessments will be made by other investigators unaware of the treatment regimen used.

After treatment (day 0), follow up assessments will be performed on days 4, 7,10 then again at day 14 after which they will leave the study. Any adverse events or side effects from the treatments will be monitored during the study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
4 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female patients over the age of 4 who are found to have a head lice infection.
  • Patients who give written informed consent or, if the patient is under 16 years of age, whose guardian gives written informed consent to participate in the study.
  • Available for the duration of study i.e. 15 days.

排除标准

  • Patients with a known sensitivity to pyrethroid, organophosphate, and/or carbamate insecticides, sensitivity to chrysanthemums and/or known sensitivity to paraben preservatives.
  • Patients who have been treated with other head lice products within the last 4 weeks.
  • Patients who have undergone a course of antibiotic treatment within the last 4 weeks.
  • Patients who have any persistent skin disorder of the scalp (i.e. eczema, chronic dermatitis, psoriasis).
  • Patients with asthma
  • Patients whose hair has been bleached, colour treated or permed within the last 4 weeks.
  • Pregnant or nursing mothers.
  • Patients who have participated in another clinical trial within 1 month prior to entry to this study.
  • Patients who have already participated in this clinical trial.

研究组 & 干预措施

10% Cocamide diethanolamine

Experimental

10% Cocamide DEA aqueous lotion is applied directly to dry hair on a single occasion and is washed off with shampoo after 60 minutes.

干预措施: Cocamide diethanolamine (Drug)

1% permethrin creme rinse

Active Comparator

1% permethrin creme rinse is applied to shampooed and towel dried hair on a single occasion and left in situ for 10 minutes, then rinsed off with clean water.

干预措施: Permethrin (Drug)

结局指标

主要结局

Elimination of infestation

时间窗: 14 days

No evidence of active head lice infestation 14 days after enrolment.

次要结局

  • The number of participants with treatment related adverse events as a measure of safety(14 days)

研究者

发起方
Medical Entomology Centre
申办方类型
Industry
责任方
Principal Investigator
主要研究者

Ian F Burgess

Director

Medical Entomology Centre

研究点 (1)

Loading locations...

相似试验